This article describes the Synthesis of labelfc and hapten-protein conjugates for use in bio-and chemiluminescent immunoassay Systems, together witn the problems encountered.
Introduction
There are two distinct types of label used in luminescence immonoassays, which are usually referred to äs chemiluminescent and bioluminescent marker substances. The difference äs far äs the assay technique itself is concerned, is only in the way in which the light is produced at the end of all reaction Steps. Labels commonly used in bioluminescence immunoassays are kinases (l, 2, 3) and NAD(P)-dependent dehydrogenases (4, 5) .
Difficulties arise in stabilising bioluminescent labels in liquid form however, äs the enzymes present are inhibited by conventional antimicrobial agents such äs azide or merthiolate.
Chemiluminescent labels include derivatives of isoluminol (6, 7, 8) , acridinium esters (9), azoluminol (10) and fluorescein isothiocyanate (11) .
Useful labels examined in this study are pyruvate kinase (EC 2.7.1.40) äs bioluminescence-(1^3), diazpluminol (10) and N-(4-aminobutyl)-N-ethylisoluminol hemisuccinamide active ester äs chemiluminescence labels.
The bioluminescent System is based ori" an ATP-gerierating System coupled to a firefly lüciferin=4ucife-fase light generating reaction (1) (2) (3) . A species-specific antibody is labelled, which results in the formation of a pyruvate kmase-immunbglobulin G conjugate.
Coupling reactions have been tested using different heterobifunctional reagents (l, 12) having a maleimide and N-hydroxysuccinimide functional group for coupling via thiol and aminogroups respectively. This type of reagent is far superior to alternative reagents such äs pentane-l,5-dial, carbodiimides or mixed anhydride reactions. The reaction is a twostep one, the first being the aminoacylation of the IgG followed by the formation of a thioether with the pyruvate kinase.
The optimisation of Signal to noise ratio in terms of the maximum and unspecific binding has been studied in terms of reagent and reactant purity and degree of Substitution of the label.
The somewhat complicated synthesis of N-(4-aminobutyl)-N-ethylisoluminol hemisuccinamide active ester (8) described in the literature was replaced by a simpler method which could be performed in almost any laboratory.
Tab. l. Reactions catalysed by the kinases used in this study. All , reactions were "driven" in the direction of ATP formation. Explanations: Adenylate kinase is also known äs myokinase. All reactions could be run in the reverse direction äs only an exchange of high energy phosphate bonds took place.
Materials and Methods

Materials
Unless otherwise stated, materials were obtained from the same sources äs in the first part of this publication (14). Pyruvate kinase, acetate kinase and adenylate kinase (myokinase) were purchased from Boehringer-Mannheim, Mannheim, D.
All heterobifunctional reagents were obtained from Sigma, Munich, D, except for the n-hexanoyl derivative, which was a gift from Boehringer-Mannheim.
ATP-monitpring kits arid N-(4-aminobutyl)-N-ethyIisoluminol hemisuccinamide were bought from LKB, Munich, äs were the gels Ultrogel A4 and A6.
Glutathione (reduced form), 5,5 / -dithiobis(2-nitrobenzoic acid), adenosine diphosphate (ADP) and phosphoenolpyruvate were obtained from Sigma, Munich.
Buffer sübstances were purchased from Merck, Darmstadt, D., and from EGA-Chemie, (Aldrich) Steinbach, D.
Methods
Effects of maleimide upon monitoring reagent and pyruvate-, acetate-and adenylate kinase activity
All enzyme reactions were run in the "reverse" direction, synthesising adenosine triphosphate (ATP) from the relevant components. The enzyme reactions are shown in Table 1 .
First the effect of maleimide upon the ATP-monitoring reagent was studied, to check for Inhibition of light production in the luciferin-luciferase System.
Increasing amounts of maleimide (covering the ränge 0.1-125 mmol/tübe) were added to suitable dilutions öf the enzymes in incubatiön buffer (0.05 raol/1 Tns-HCl containing 2.5 g/l bovine serum albiimin and 0.1 mol/1 KC1 adjusted to pH 7.4), the effects on the rate of ATP synthesis being plotted against time. ATP production was measured kinetically using an ATP-monitoring kit and an LKB 1250 Luminometer with printer display (see section "Studies upon the effect . . ." for detailed Information).
Synthesis of the pyruvate kinase IgC conjugates
The -globulin fraction of a donkey anti-rabbit IgG serum (Wellcome RD 17) was prepared using polyethylene glycol precipitation followed by DEAE-cellulose column chromatography, (2, 15) . The IgG concentration was around 15 g/l in the eluate.
To a solution of IgG (15 g/l) containing a total of 15 mg dissolved in l ml buffer 2 (0.02 mol/1 potassium phosphate containing 0.15 mol/ NaCl, adjusted to pH 7) was added l ml of the respective heterobifunctional reagent (for structure of these reagents see fig. 1 .) representing l umol^-lO (see section "Studies upon the effect..." below). The mixture was incubated for 45 min at ambient temperature and then dialysed twice for l h against 11 buffer 2. The degree of coupling was determined by the titration of the free thiol groups on the IgG-heterobifunctional reagent complex with Ellman's reagent (5,5'-dithiobis-(2-nitrobenzoic acid)) in which 2-nitro-5-mercaptobenzoic acid is produced in the presence of free -SH groups. The latter gives an intensive yellow coloufed anion which can be measured photometrically at 412 nm (16, 17) . A Standard curve was set up using reduced glutathione äs calibratpr covering the ränge 0-50 nmol/tube.
In order to obtain a label with a higher molar ratio pyruvate kinase: IgG, the pyruvate kinase concentration was held at 4 times that of IgG. The reaction was allowed to proceed for 25 min at room temperature and was stopped by addition of 100 nmol reduced glutathione. The mixture was then separated on an Ultrogel A6 column (100 x 1.8 cm) using buffer 2 äs eluent. The antibody binding potency and enzyme activity were tested in each fraction, the optimal fractions showing both enzyme activity and specific antibody binding pooled, portioned and lyophilised after addition of l mg lactose to each portion. The pyruvate kinase activity was tested for äs already described (1), the antibody binding potency by binding studies using rabbit IgG covalently coupled to polystyrene balls (14).
Studies upon the effect of heterobifunctional reagent concentration with respect to enzyme activity
The effect upon enzyme activity after coupling to IgG was studied using three different concentrations of succinimidyl-4-(N-malc- The same System was used to calculate the K m value for phosphoenolpyruvate. Here the ADP concentration was kept constant at 6 g/l, the concentrations for phosphoenolpyruvate were varied s described above for ADP. The K m value for "free" pyruvate kinase was measured using a 10 μΐ aliquot, equivalent to l ng/tube.
Lineweaver-Burk plots were made in order to derive the K mvalues for ADP and phosphoenolpyruvate/
Diaiotisation of luminol and isoluminol
On account of conflicting reports in the litefature (10) and personal expef ience, the effects of diazotisation time, pH and Substitution rate into IgG have been studied. Binding studies have been carried out using the relevant IgG against which the labelled antibody is directed, coupled to polystyrene balls (14).
Luminol or isoluminol (l mmol) was suspended in 5 ml l mol/1 HCI and cooled under constant stirring to 0 °C (ice bath). KNO( 1.5 mmol) was dissolved in l ml distilled water and cooled in ice. The cold KNO 2 solution was added dropwise to the luminol/isoluminol Suspension respectively, until the green-yellow slurry became a clear orange (luminol) or yellow-orange (isoluminol) solution. The time taken for the addition of nitrite was 15-20 min. An excess of HNO? is usually undesirable if the diazotised reacr tant is to be used straight away because of further unwanted diazotisation of the second reactant, here IgG. In this case, s IgG molecules contain no arylamino groups, no such side reactions should occur. However, the presence of excess nitrite ions were tested for using starch iodide paper, a blue^black coloration denoting the presence of nitrite. This was removed by adding a few drops of urea solution (l mol/1) until the reaction with starch-iodide paper was negative. The diazoluminol or diazoisoluminol was •used immediately for the preparation of labels. The diazo con> pounds were stable for periods up to 7 days at -20 °C, but even during this time, their effectiveness s coupling reagents deteriorated. A quick test to see if the diazoluminol was still useable was that if, after addition of a drop of K 2 CO 3 (l mol/1) the red c lorat ion was stable for more than 30 minutes it could still be used for coupling. In the case of diazoisoluminol, the yellow orange solution turned golden yellow and crystallised out inside 30 minutes after beeing synthesised. The resulting Suspension was used for conjugation to IgG.
^ ?-· * imidomethyl)-cyclohexane-l-carboxylate, with a molar ratio IgG: succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1 -carboxylate of 1:1.2, 1:6 and and 1:10.
Conjugates were made s in section above, but with additional purification after the succinimidyl-4-(N-maleimidomethyl)-cyclohexane-1-carboxylate-IgG coupling using a Sephadex G-25 column (30 x 1.5 cm). Pyruvate kinase was allowed to react in a four-fold excess, and the optimal fractions (see above) used to calculate the Michaelis-Menten constant. The necessary experiments were carried out s set out below:
100 μΐ of a 1:600 dilution of the conjugate (ca. 2.8 pg IgG) were reacted with a rabbit IgG-coated polystyrene ball (14) in 200 ul incubation buffer for 3 h at ambient temperature (23 °C). The polystyrene ball was then washed with incubation buffer (2 x 500 ul) and 0.15 mol/1 NaCl (l x 500 ul).
The measurement of ATP production in order to calculate the Km-value for ADP was carried out using the following System: 
Preparation of diazoluminol· and diazoisoluminol·antibody conjugates
These experiments were carried out to check the effect of pH, time and the ratio of coupling reagent to IgG oh the q ality of the products formed.
The diazoluminol or diazoisoluminol preparation was added slowly to l ml of the IgG solution (15 g/l) in buffef 2 under constant stirring in an ice bath to give final ratios of diazoluminol/diazoiscn luminohlgG of 20:1. The re ction times were 6, 24 and 72 h at pH 4 and pH 9 at 4°C. Potassium carbonate solution (l mol/1) was added dropwise to maintain the pH between 9.0 and 9.2. The reactions at pH 4 were carried out maintaining the pH with 0.5 mol/1 potassium phosphate buffer pH 7.
After the addition of diazotised (iso)Iuminol, the reaction was allowed to proceed at 4 °C during which time the reaction mixture changed from red to yellow in case of pH 9 derivatives, those at pH 4 remaining pale yellow throughout the coupling procedure.
After the reaction all reation mixtures were purified over an Ultrogel A4 column (30 x 2.5 cm) with buffer 2 s eluent, collecting 30 drop fractions (1.5 ml). The coloured fractions were tested for specific and unspecific binding to IgG and transferrin coated polystyrene balls respectively (14).
To check the effect of changing the ratio lurninogen: IgG diazoluminol was used at pH 9 with a 24 h reaction time at 4 °C s these conditions were optimal.
The ratio of diazoluminol: IgG was varied between 8: l and 200: l. Separation of the reaction componenls was made with an Ultrogel A4 (see above).
From the resulting data it was estimated that an effective (immunoreactive) Substitution of 23-28 gentamicin per bovine serum albumin had taken placc.
Optitnised preparation of N-(4-aminobutyl) -N-ethylisoluminol hemisuccinamide active ester
18.5 mg (50 μιηοΐ) N-(4-aminobutyl)-N-ethyIisoIuminol hcmisuccinamide wcre dissolved in 800 μΐ dry dimethylformamide under slight warming. N-Hydroxysuccinimide (5.75 mg = 50 μπιοί) was added at room temperature, the mixture being stirred. When the N-hydroxysuccinimide had been dissolved, 30.9 mg (150 μηηοΐ) dicyclohexylcarbodiimide dissolved in 200 μΐ dry dimethylformamide were added. After 20 h at room temperature without stirring and under light exclusion (aluminium foil covered reaction vessel) the mixture was used for direct coupling to antibodies and antigens. During the reaction, crystals of dicyclohexyl urca precipitated out.
A low temperature of about 4 °C slows down the formation of the active ester and an increase in incubation time at room temperature (>20 h) gave no increase in N-(4-aminobutyl)-N-ethylisoluminol hemisuccinamide active ester formation.
Product formation was confirmed using thin layer Chromatographie techniques. 
Preparation of N-(4-aminobutyl)-N-ethylisoluminol hemisuccinamide active ester-antibody conjugates
The γ-globulin fraction of a donkey anti-rabbit IgG serum was prepared s described in Section Synthesis . . .". To 3 x 2 ml (30 mg protein) portions of this preparation different amounts of the N-(4-aminobutyl)-N-ethylisoIuminol hemisuccinamide active ester preparation were added to give final ratios N-(4-aminobtyl)-N-ethylisoluminol hemisuccinamide active ester: IgG of 30:1, 60:1 and 120:1 respectively. After the addition, a precipitate of water insoluble components formed immediately. The reaction was allowed to continue for 24 h at 4 °C under light exclusion. After centrifugation (10 min at 4000 min"" 1 ) the supernatant was transferred to an Ultrogel A4 (30 x 2.5 cm) column using 0.05 mol/1 tris/HCl pH 8 s eluent, collecting fractions of 1.5ml.
The test System for specific and unspecific binding was identical with that described in the preparation of diazoluminol and diazoisoluminol-IgG.
Synthesis of a gentamicin-bovine serum albumin conjugate for the gentamicin SPALT assay (see tab. 2)
The coupling reagefit used was l-cyclohexyl-3-(2-mofpholinyl-(4)-i etllyl)-carbodiimide methyl-p-toluene sulphonate (MCDI). The molar ratios ch sen were: bovine serum albumin: carbodiimide (MCDI): gentamicin -1:60:80. Bovine serum albumin (68 mg) and 48 mg gentamicin were dissolved in 4 ml distilled water and the pH adjusted to 4.5 with dropwise addition of 0.1 mol/1 HC1. Carbodiimide (MCDI, 28 mg) were dissolved in 500 μΐ distilled water and added dropwise to the bovine serum albumingentamicin mixture. The pH of the resulting mixture was held constant at 4.5 with 0.1 mol/1 HC1 for the next hour after which the reaction was ailowed to proceed at 4°C overnight.
Seperation of complex and unreacted gentamicin was effected via an Ultrogel A6 column (30 x 2.5 em) using buffer 2 s elution buffer. The column fractions were tested for protein conterit ) and gentamicin immunoreactivity (radioimmunoassay).
Synthesis of a thyroxine-transferrin conjugate for a 7VSPALTas-say
This conjugate was synthesized for the T 4 -SPALT assay in part III of this trilogy and is described here s it is part of the preparation for an assay.
The coupling reagents ch sen were l-cyclohexyl-3-(2-morpholinyl-(4)-ethyl)-carbodiimide methyl-p-toluene sulphonate (see above) or l-ethyl-3-(3-dimethyl aminopropyl)carbodiimide hydrochloride (EDAC).
The molar ratios ch sen were: Transferrin:carbodiimide(EDAC):thyroxine -1:50:200.
44 mg transferrin were dissolved in 500 μΐ distilled water and the pH adjusted to 6 using 0.1 mol/1 HC1. 20 mg thyroxine were suspended in l ml distilled water and brought into solution by dropwise addition of 0.5 mol/1 NaOH. The carbodiimide solution was added dropwise to the transferrin solution keeping the pH at 6, the mixture bcing ailowed to stand for 5 minutes. The thyroxine solution was given dropwise to the mixture over a period of 90-120 minutes, keeping the pH between 6 and 6.5. The mixture was then ailowed to stand overnight at 4 °C. The thyroxine did not all remain in solution with l-ethyl-3-(3-dimethyl aminopropyl)carbodiimide hydrochloride s coupling reagent. The high molar ratio of thyroxine was meant to compensate for possible precipitation during the reaction, s it was known that it is almost impossible to keep thyroxine in aqueous solution at pH values lying on the acid side of neutrality.
The purification of the conjugate was via an Ultrogel A6 column (30 x 2.5 cm) using centrifugation step before the column run to remove particulate material.
The Substitution rate was determined spectrophotometrically using the molar lineic absorbance for thyroxine at 328 nm s 56 m 2 · mol' 1 .
The Substitution rate with l-cyclohexyl-3-(2-morpholinyl-(4)-ethyl)-carbodiimide methyl-p-toluene sulphonate was 16 thyroxine per transferrin and for l-ethyl-3-(3-dimethyl aminopropyl)-carbodiimide hydrochloride 24 thyroxine per transferrin. Figure 2 shows the effect of maleimide on acetateand adenylate-(or myo-) kinase, figure 3 on the ATP-monitoring reagent. The assay conditions were identical to those already published, (3), replacing the microcrystalline cellulose by the antigen-coated polystyrene ball and omitting the centrifugation Steps. Results given s millivolt/second (mV/s) reflecting the rate of ATP production.
Results
Bioluminescent conjugates
to rabbit IgG coated polystyrene balls. All s bsequent tests were made with the donkey anti rabbit IgG-succinimidyl-4^(N-maleimiclomethyI)-cyclohexane-1-carboxylate-pyruvate kinase conjugate s this performed best. Figure. ^^shaws the Lineweaver* Burk plots to test the effect on the enzyme kinetics after coupling pyruvate kinase to IgG. Figure 5 shows the relative light intensity generated by diazoluminol, diazoisoluminol and N-(4-aminobutyl)-N-ethylisoluminol hemisuccinamide under identical conditions. The detection limit of diazoisoluminol is around 3 decades higher than that for diazoluminol. The detection limit of (N-(4-aminobutyl)-N-ethylisoluminol hemisuccinamide is sirhilar to that for diazoluminol.
Chemiluminescent conjugates
The results from the preparation of antibody conjugates using diazoluminol and diazoisoluminol agreed in parts with other studies (10), however differ in that in this läböratory mainly diazoluminol, and not diazoisoluminol, conjugates have been found to be mofe suitable. Diazoisoluminol gave no useable conjugates with antibodies ät the pH arid incubation times tested here.
Figüre 6 shows the effect of testing the binding of the column eluates of diazoluminol and diazoisoluminol donkey-anti-rabbit IgG conjugates to räbbit IgG coated polystyrene balls (= Bö or specific binding) and to transferriii-coated balls äs protein-coated balls not containing räbbit IgG (= ÜB or unspecific binding) under identical conditions namely: 2 elüate, 300 incubation buffer and a coated polystyrene ball were incubated at ambient temperature for l h, All measurements performed on an LKB 1251 Luminometer. Assay conditions: For B -rabbit IgG coated polystyrene balls For B -human transferrin coated balls 10 μΐ column eluate, 300 μΐ incubation buffer and l coated polystyrene ball were incubated for 60 min at ambient temperature, washed with l x l ml incubation buffer containing 0.5 ml/l Tween 20, followed by l x l ml 0.15 mol/1 NaCl. washed with l x l ml incubation buffer and l X l ml 0.15 mol/1 NaCl, then transferred to the luminometer where the light emission was initiated.
As can be seen, the diazoisoluminol conjugate shows a much lower specific binding than the diazoluminol conjugate, showing that isoluminol derivatives could not be used in that way in any assay Systems.
At pH 4 diazoluminol gave no useful conjugates. When using diazoluminol a reaction time of 24 h at 4 °C gave optimal results. Shorter incubation times gave a lower Substitution rate, whereas incubation times longer than 24 h did not give rise to better conjugates. Table 3a shows the effect of the Substitution ratio of diazoluminol: donkey anti rabbit IgG, the optimal Substitution rate being around 40: l s far s the signal to noise ratio (B 0 /UB) was concerned. Figure 7 shows the effect of the molar ratio diazoluminol: IgG on the binding characteristics of the Ultrogel A4 column fractions. 10 μΐ per fraction were tested analogically to the conditions described above for figure 6.
It can be seen that a higher Substitution rate only led to a dramatic increase in the nspecific binding s can be seen in the 1:100 curve. Table 3b shows the comparison between maximal (B ) and nspecific binding ( B) for different N-(4-aminobutyl)-N-ethylisoluminol hemisuccinamide active ester donkey anti rabbit IgG conjugates using different Substitution ratios.
A Substitution ratio of about 60: l· gave the best results, a higher Substitution of 120:1 giving a higher noise to signal ratio (UB/B 0 ). Lower Substitution ratios gave a lower light intensity but no difference in the ratio UB/B 0 . 
Discession
The pfoblems and possible Solutions for set up solid phase based luminescence immunoassays have been limited to the preparation of luminescence conjugates and hapteii-pfotein conjugates in the second paft of this trilogy.
The bioluminescent labels here described show the problems of working with kinases, that is the coupling of kinases to antigens or antibodies without loss of antigenic or enzymatic actjvity. Of all kinases tested only pyruvate kinase was robust enough to "survive" coupling using the heterobifunctional reagents tested here. The other kinases, although attraetive on paper, for example adenylate kinase with its molecular weight of 21000, resistanee to acid pH, high turnover rate and single Substrate (ADP) were unable to be used due to their sensitivity to maleimide. Other coupling reagents (carbodiimides, pentane-l,5-dial, bisfcpoxirane) were found to be unsuitable äs the enzyme activity disappeared during coupling. The results show that pyruvate kinase, despite its high molecular weight (240000) was used beeause of available SH-groups not present in the active centre. Whether the use of SH-group introducing reagents such äs (N-succinimidyl 3-(2-pyridyldithio) propionate) could make the other kinases useable, is a point worth considering.
The results from the Lineweaver-Burk plots confirmed that the coupling reagents here chosen led to changes in enzyme activity and structure, äs measured by Substrate affinity. As previously stated (1), difficulties of finding a suitable antimicrobial reagent for bioluminescent labels of this type presents a major drawback, which suggests that such labels should only be used where insufficient sensitivity can be obtained with chemiluminescent labels. The latter do not suffer such problems, partly due to their hydrazide structure in the case of diazoluminol, which in itself appears to exert bacteriostatic properties.
Many of the chemiluminescent labels described in the literatüre suffer from the drawback that their synthesis is somewhat complicated (6). The labels described here are simple to produce, and do not require much expertise and equipment, äs well äs giving out sufficient light for most purposes, althoügh N-(4-aminobutyl)-N-ethylisoluminol hemisuccinamide gave the best results. Diazoluminol conjugates have in contrast to diazoisoluminol conjugates a higher light Output (10). The reaction of diazoisoluminol in the presence of proteins was far quicker than of diazoluminol, äs monitored by the decolorisation. This may be explained by the active diazogroup, which in isoluminol is located on the less sterically hindered 6 (4)-position. Diazoluminol is not äs reactive due to the position of the oxo-group on the azine ring, and due to its ability to build ä stable internal structure (see fig. 8 ). The reaction of proteins with diazoluminol could be divided into two distinct phases, a rapid reaction with the protein in alkaline solution (pH 9-10) in which the reaction mixture remained red (excited electrons in the diazo bridge are still present). Such conjugates are stable enough to be separated on an agarose gel column (Ultrogel A4 or A6), however they are unstable enough to transfer the diazoluminol group to another protein if the latter is present in excess. At this stage a transitional bonding is present in which both ionic and covalent components are present. The second stage of the reaction is slower and is associated with a disappearence of the red coloration, and the appearance of a yellow-orange colour, in which the covalent bonding is stable. These conjugates can be stored at -20 °C for over a year without appreciable loss in immunological and luminogenic activity. An important point to mention here, is that the materials to be diazotised must be free from azide, äs diazoluminol reacts with sodium azide to form compounds which do not react with the tyrosine moieties of the protein.
Here the decolorisation of the reaction mixture takes place within seconds, a yellöw solution being formed. If this solution is then adjusted to pH 7 with phosphate buffer, it darkens due to reaction with atmospheric oxygen, suggesting that poly^phenol derivatives may be formed. This would be in accordance with a free radical reactiqn following the loss of nitrogen from the diazoluminol-azide complex. These unwanted effects can be avoided by treatment öf the material to be diazotised with DEAE cellulose in the form of a short column (2, 15), äs already described. Finally, it can be stated that the choice of label used, i.e., whether chemi-or bioluminescent depends to a large extent upon the sensitivity of the assay, and although the assays described to date mäinly use the former (7, 8, 9) , the latter may have to be used until sufficient sensitivity can be achieved using chemiluminescent markers.
